本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CALIDI BIOTHERAPEUTICS INC

1.27
+0.03002.42%
成交量:7,084
成交額:8,736.27
市值:328.19萬
市盈率:-0.04
高:1.27
開:1.27
低:1.27
收:1.24
52周最高:27.84
52周最低:1.22
股本:258.42萬
流通股本:255.54萬
量比:0.78
換手率:0.28%
股息:- -
股息率:- -
每股收益(TTM):-33.3374
每股收益(LYR):-95.1334
淨資產收益率:-672.22%
總資產收益率:-134.79%
市淨率:1.05
市盈率(LYR):-0.01

資料載入中...

2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/15

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

重要事件披露

Form 8-K - Current report
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/07

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/01

重要事件披露

Form 8-K - Current report
2024/01/29

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/01/17

SEC問詢函

Form CORRESP - Correspondence
2024/01/16

SEC問詢函

Form CORRESP - Correspondence
2024/01/16

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/08

SEC問詢函

Form CORRESP - Correspondence
2024/01/08

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]